111 related articles for article (PubMed ID: 27500458)
1. Active hexose correlated compound modulates LPS-induced hypotension and gut injury in rats.
Doursout MF; Liang Y; Sundaresan A; Wakame K; Fujii H; Takanari J; Devakottai S; Kulkarni A
Int Immunopharmacol; 2016 Oct; 39():280-286. PubMed ID: 27500458
[TBL] [Abstract][Full Text] [Related]
2. Lactoferrin moderates LPS-induced hypotensive response and gut injury in rats.
Doursout MF; Horton H; Hoang L; Liang Y; Hwang SA; Boyd S; Actor JK; Kruzel ML
Int Immunopharmacol; 2013 Feb; 15(2):227-31. PubMed ID: 23267765
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of Active Hexose-Correlated Compound (AHCC) combined with CpG-ODN (oligodeoxynucleotide) in B16 melanoma murine model.
Ignacio RM; Kim CS; Kim YD; Lee HM; Qi XF; Kim SK
Cytokine; 2015 Dec; 76(2):131-137. PubMed ID: 26082022
[TBL] [Abstract][Full Text] [Related]
4. Active Hexose Correlated Compound (AHCC) promotes an intestinal immune response in BALB/c mice and in primary intestinal epithelial cell culture involving toll-like receptors TLR-2 and TLR-4.
Mallet JF; Graham É; Ritz BW; Homma K; Matar C
Eur J Nutr; 2016 Feb; 55(1):139-46. PubMed ID: 25596849
[TBL] [Abstract][Full Text] [Related]
5. Modulation of T Regulatory and Dendritic Cell Phenotypes Following Ingestion of
Chowdhury AH; Cámara M; Verma C; Eremin O; Kulkarni AD; Lobo DN
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31618905
[TBL] [Abstract][Full Text] [Related]
6. The Effects of AHCC®, a Standardized Extract of Cultured
Shin MS; Park HJ; Maeda T; Nishioka H; Fujii H; Kang I
J Immunol Res; 2019; 2019():3758576. PubMed ID: 31930148
[TBL] [Abstract][Full Text] [Related]
7. Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses.
Gao Y; Zhang D; Sun B; Fujii H; Kosuna K; Yin Z
Cancer Immunol Immunother; 2006 Oct; 55(10):1258-66. PubMed ID: 16362410
[TBL] [Abstract][Full Text] [Related]
8. San-Huang-Xie-Xin-Tang reduces lipopolysaccharides-induced hypotension and inflammatory mediators.
Lo YC; Tsai PL; Huang YB; Shen KP; Tsai YH; Wu YC; Lai YH; Chen IJ
J Ethnopharmacol; 2005 Jan; 96(1-2):99-106. PubMed ID: 15588656
[TBL] [Abstract][Full Text] [Related]
9. N-acetylcysteine abrogates acute lung injury induced by endotoxin.
Kao SJ; Wang D; Lin HI; Chen HI
Clin Exp Pharmacol Physiol; 2006; 33(1-2):33-40. PubMed ID: 16445696
[TBL] [Abstract][Full Text] [Related]
10. CNI-1493 attenuates hemodynamic and pro-inflammatory responses to LPS.
Molina PE; Qian L; Schuhlein D; Naukam R; Wang H; Tracey KJ; Abumrad NN
Shock; 1998 Nov; 10(5):329-34. PubMed ID: 9840647
[TBL] [Abstract][Full Text] [Related]
11. Effect of active hexose correlated compound on the production of nitric oxide in hepatocytes.
Matsui K; Kawaguchi Y; Ozaki T; Tokuhara K; Tanaka H; Kaibori M; Matsui Y; Kamiyama Y; Wakame K; Miura T; Nishizawa M; Okumura T
JPEN J Parenter Enteral Nutr; 2007; 31(5):373-80; discussion 380-1. PubMed ID: 17712145
[TBL] [Abstract][Full Text] [Related]
12. Adenosine, a hepato-protective component in active hexose correlated compound: its identification and iNOS suppression mechanism.
Tanaka Y; Ohashi S; Ohtsuki A; Kiyono T; Park EY; Nakamura Y; Sato K; Oishi M; Miki H; Tokuhara K; Matsui K; Kaibori M; Nishizawa M; Okumura T; Kwon AH
Nitric Oxide; 2014 Aug; 40():75-86. PubMed ID: 24878381
[TBL] [Abstract][Full Text] [Related]
13. AHCC
Park HJ; Boo S; Park I; Shin MS; Takahashi T; Takanari J; Homma K; Kang I
Front Immunol; 2022; 13():875872. PubMed ID: 35514996
[TBL] [Abstract][Full Text] [Related]
14. A Phase I study of the safety of the nutritional supplement, active hexose correlated compound, AHCC, in healthy volunteers.
Spierings EL; Fujii H; Sun B; Walshe T
J Nutr Sci Vitaminol (Tokyo); 2007 Dec; 53(6):536-9. PubMed ID: 18202543
[TBL] [Abstract][Full Text] [Related]
15. Active hexose correlated compound inhibits the expression of proinflammatory biomarker iNOS in hepatocytes.
Matsui K; Ozaki T; Oishi M; Tanaka Y; Kaibori M; Nishizawa M; Okumura T; Kwon AH
Eur Surg Res; 2011; 47(4):274-83. PubMed ID: 22076046
[TBL] [Abstract][Full Text] [Related]
16. Genotoxicity and subchronic toxicity evaluation of Active Hexose Correlated Compound (AHCC).
Fujii H; Nishioka N; Simon RR; Kaur R; Lynch B; Roberts A
Regul Toxicol Pharmacol; 2011 Mar; 59(2):237-50. PubMed ID: 20951179
[TBL] [Abstract][Full Text] [Related]
17. Niacinamide abrogates the organ dysfunction and acute lung injury caused by endotoxin.
Kao SJ; Liu DD; Su CF; Chen HI
J Cardiovasc Pharmacol; 2007 Sep; 50(3):333-42. PubMed ID: 17878764
[TBL] [Abstract][Full Text] [Related]
18. Short-term supplementation with active hexose correlated compound improves the antibody response to influenza B vaccine.
Roman BE; Beli E; Duriancik DM; Gardner EM
Nutr Res; 2013 Jan; 33(1):12-7. PubMed ID: 23351405
[TBL] [Abstract][Full Text] [Related]
19. The effect of active hexose correlated compound in modulating cytosine arabinoside-induced hair loss, and 6-mercaptopurine- and methotrexate-induced liver injury in rodents.
Sun B; Wakame K; Sato E; Nishioka H; Aruoma OI; Fujii H
Cancer Epidemiol; 2009 Oct; 33(3-4):293-9. PubMed ID: 19699163
[TBL] [Abstract][Full Text] [Related]
20. Pneumotoxicity of lipopolysaccharide in nitric oxide-deficient rats is limited by a thromboxane synthase inhibitor.
Wołkow PP; Bartuś JB; Gryglewski RJ
J Physiol Pharmacol; 1997 Dec; 48(4):645-53. PubMed ID: 9444613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
